Senior Research Scientist at Beam Therapeutics Inc.
Brookline, Massachusetts
- Cell biologists with a focus on designing novel pre-clinical cell-based assays for disease/therapeutic areas, including heart, liver, and stem cell therapies - R&D experience with tissue engineering of stem cell and primary cell cultures - Experience managing academic-industry partnerships, including pharmaceutical, biotech, CRO, and start-up companies - Authored/co-authored 12 scientific manuscripts and wrote/co-wrote 7 awarded government-funded...
- Cell biologists with a focus on designing novel pre-clinical cell-based assays for disease/therapeutic areas, including heart, liver, and stem cell therapies - R&D experience with tissue engineering of stem cell and primary cell cultures - Experience managing academic-industry partnerships, including pharmaceutical, biotech, CRO, and start-up companies - Authored/co-authored 12 scientific manuscripts and wrote/co-wrote 7 awarded government-funded grants (NIH, NSF, DARPA)Product Development/DMPK Scientist @ -Develop external collaborations and experimental protocols to build novel pre-clinical liver models for predicting drug disposition and toxicity -Work cross-functionally with ADME/Toxicology scientists to develop tissue engineered liver models that predict drug-induced liver injury (DILI) -Develop research and analytical methods for metabolic stability in tissue-engineered liver models -Manage and write proposals for government-funded grant opportunities -Interface with marketing and sales teams to publish scientific marketing materials From 2013 to Present (2 years) Postdoctoral Fellow @ • Served as project team leader and team participant in academic-industry collaborations between Harvard University and start-up, biotech, and pharmaceutical companies • Designed in vitro cell based assays to test functional maturation of stem cell-derived cardiomyocytes • Co-wrote grant proposals on the design of organs-on-a-chip technologies for testing pre-clinical safety and efficacy of drugs used to treat cardiovascular disease • Organized and conducted laboratory site visits to establish academic-industry collaborations with numerous domestic and international biotech and pharmaceutical companies • Completed Harvard University courses in clinical and translational medicine From 2010 to 2013 (3 years) Postdoctoral Scholar @ • As first postdoc in a startup lab, instrumental in developing the scientific direction that remains the focus of the 15-person lab to date. Published 7 articles in cell motility within first 3 years of operation • Organized and lead a 4-postdoc team to design novel contractility assays for myocardial infarction From 2007 to 2010 (3 years) PhD, Cell Biology @ Northwestern University - The Feinberg School of Medicine From 2003 to 2007 MS, Mechanical Engineering @ Northwestern University From 2000 to 2003 BS, Engineering Mechanics @ University of Illinois at Urbana-Champaign From 1996 to 2000 Yvonne Aratyn-Schaus is skilled in: Mammalian Cell Culture, Molecular & Cellular Biology, Fluorescence Microscopy, Confocal Microscopy, organs on a chip tecnology, Thin Films, micro-contact printing technology, fluorescence recovery after photobleaching, traction force microscopy, development of in vitro cell based assays, DNA and siRNA transfection, Cell Migration, cell proliferation, Neurodegeneration, Stem Cell Research
-Develop external collaborations and experimental protocols to build novel pre-clinical liver models for predicting drug disposition and toxicity -Work cross-functionally with ADME/Toxicology scientists to develop tissue engineered liver models that predict drug-induced liver injury (DILI) -Develop research and analytical methods for metabolic stability in tissue-engineered liver models -Manage and write proposals for government-funded grant opportunities -Interface with... -Develop external collaborations and experimental protocols to build novel pre-clinical liver models for predicting drug disposition and toxicity -Work cross-functionally with ADME/Toxicology scientists to develop tissue engineered liver models that predict drug-induced liver injury (DILI) -Develop research and analytical methods for metabolic stability in tissue-engineered liver models -Manage and write proposals for government-funded grant opportunities -Interface with marketing and sales teams to publish scientific marketing materials
What company does Yvonne Aratyn-Schaus work for?
Yvonne Aratyn-Schaus works for Hepregen Corporation
What is Yvonne Aratyn-Schaus's role at Hepregen Corporation?
Yvonne Aratyn-Schaus is Product Development/DMPK Scientist
What industry does Yvonne Aratyn-Schaus work in?
Yvonne Aratyn-Schaus works in the Biotechnology industry.
Who are Yvonne Aratyn-Schaus's colleagues?
Yvonne Aratyn-Schaus's colleagues are Shane Larson, John Evans, Giuseppe Ciaramella, Francine Gregoire, Christine Bellon, Christopher Hill, Terry-Ann Burrell, Stephen PhD, and Yeh-Chuin Poh
Enjoy unlimited access and discover candidates outside of LinkedIn
One billion email addresses and counting
Everything you need to engage with more prospects.
ContactOut is used by
76% of Fortune 500 companies
Yvonne Aratyn-Schaus's Social Media Links
www.eperni...